Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy | MicrobiomeTrials← Back to trialsNCT02262832
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2014-10-09Est. Completion: 2027-07-31
Enrollment target: 24 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Generalized Lipodystrophy
This study is researching an experimental drug called mibavademab. The study is focused on participants with GLD who hav…
Bethesda, United StatesCompleted Jul 9, 2026
Nephrotic SyndromeLipodystrophyMetabolic SyndromeHealthy VolunteerDiabetesMetabolic Associated Steatotic Liver Disease
Background:
Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn mo…
Bethesda, United States
Est. completion Feb 1, 2030
DiabetesLipodystrophyHyperlipidemia
Background:
\- Partial lipodystrophy can cause high blood fat levels and resistance to insulin. This can lead to health…
Bethesda, United StatesEst. completion Jul 31, 2027